These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20695841)

  • 1. Nanoparticles: a promising therapeutic approach in atherosclerosis.
    Antoniades C; Psarros C; Tousoulis D; Bakogiannis C; Shirodaria C; Stefanadis C
    Curr Drug Deliv; 2010 Oct; 7(4):303-11. PubMed ID: 20695841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
    Psarros C; Lee R; Margaritis M; Antoniades C
    Nanomedicine; 2012 Sep; 8 Suppl 1():S59-68. PubMed ID: 22640906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicine for the prevention, treatment and imaging of atherosclerosis.
    Psarros C; Lee R; Margaritis M; Antoniades C
    Maturitas; 2012 Sep; 73(1):52-60. PubMed ID: 22261366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology and atherosclerosis imaging: emerging diagnostic and therapeutic applications.
    Schoenhagen P; Conyers JL
    Recent Pat Cardiovasc Drug Discov; 2008 Jun; 3(2):98-104. PubMed ID: 18537760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.
    Dou Y; Chen Y; Zhang X; Xu X; Chen Y; Guo J; Zhang D; Wang R; Li X; Zhang J
    Biomaterials; 2017 Oct; 143():93-108. PubMed ID: 28778000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and treatment of atherosclerosis using nanoparticles.
    Zhang J; Zu Y; Dhanasekara CS; Li J; Wu D; Fan Z; Wang S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Jan; 9(1):. PubMed ID: 27241794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin E in cardiovascular disease: has the die been cast?
    Yusoff K
    Asia Pac J Clin Nutr; 2002; 11 Suppl 7():S443-7. PubMed ID: 12492632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherosclerotic plaque regression: fact or fiction?
    Shanmugam N; Román-Rego A; Ong P; Kaski JC
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):311-7. PubMed ID: 20549322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharide-based nanoparticles: a versatile platform for drug delivery and biomedical imaging.
    Saravanakumar G; Jo DG; Park JH
    Curr Med Chem; 2012; 19(19):3212-29. PubMed ID: 22612705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo evaluation of vascular-targeted spheroidal microparticles for imaging and drug delivery application in atherosclerosis.
    Namdee K; Thompson AJ; Golinski A; Mocherla S; Bouis D; Eniola-Adefeso O
    Atherosclerosis; 2014 Nov; 237(1):279-86. PubMed ID: 25286447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
    Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
    Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein-decorated and Adriamycin-loaded silica nanoparticles for tumor-targeted chemotherapy of colorectal cancer.
    Shi G; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Zhang R
    Adv Clin Exp Med; 2019 Apr; 28(4):479-487. PubMed ID: 30070081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-mediated drug delivery system for atherosclerotic cardiovascular disease.
    Matoba T; Koga JI; Nakano K; Egashira K; Tsutsui H
    J Cardiol; 2017 Sep; 70(3):206-211. PubMed ID: 28416142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlling cardiac transport and plaque formation.
    Aronis Z; Raz S; Martinez EJ; Einav S
    Ann N Y Acad Sci; 2008 Mar; 1123():146-54. PubMed ID: 18375587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology in diagnosis and treatment of coronary artery disease.
    Karimi M; Zare H; Bakhshian Nik A; Yazdani N; Hamrang M; Mohamed E; Sahandi Zangabad P; Moosavi Basri SM; Bakhtiari L; Hamblin MR
    Nanomedicine (Lond); 2016; 11(5):513-30. PubMed ID: 26906471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive effects of heregulin-beta1 on macrophage foam cell formation and atherosclerosis.
    Xu G; Watanabe T; Iso Y; Koba S; Sakai T; Nagashima M; Arita S; Hongo S; Ota H; Kobayashi Y; Miyazaki A; Hirano T
    Circ Res; 2009 Aug; 105(5):500-10. PubMed ID: 19644050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis.
    Slevin M; Badimon L; Grau-Olivares M; Ramis M; Sendra J; Morrison M; Krupinski J
    Mol Biosyst; 2010 Mar; 6(3):444-50. PubMed ID: 20174673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of drugs targeting inflammation for the management of coronary artery disease.
    Duchatelle V; Kritikou EA; Tardif JC
    Can J Cardiol; 2012; 28(6):678-86. PubMed ID: 22926034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
    Shen ZT; Zheng S; Gounis MJ; Sigalov AB
    PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of plaque rupture: a new paradigm of therapy.
    Forrester JS
    Ann Intern Med; 2002 Nov; 137(10):823-33. PubMed ID: 12435220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.